Regression of existing glomerulosclerosis by inhibition of aldosterone. - Wikidata - awgldk - TriplyDB

Regression of existing glomerulosclerosis by inhibition of aldosterone.

Regression of existing glomerulosclerosis by inhibition of aldosterone.

http://www.wikidata.org/entity/Q46726706

about

Aldosterone antagonists for preventing the progression of chronic kidney disease Aldosterone antagonists for preventing the progression of chronic kidney disease Aldosterone antagonists for preventing the progression of chronic kidney disease Hypoxia: The Force that Drives Chronic Kidney Disease Therapeutic targeting of aldosterone: a novel approach to the treatment of glomerular disease Mechanisms of disease reversal in focal and segmental glomerulosclerosis Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis.Cellular and molecular mechanisms in kidney fibrosis.The impact of obstructive sleep apnea on chronic kidney disease.Obesity in kidney disease: A heavyweight opponent.Metabolic acidosis and the progression of chronic kidney disease.Regression of albuminuria and hypertension and arrest of severe renal injury by a losartan-hydrochlorothiazide association in a model of very advanced nephropathy.Increased capillary branching contributes to angiotensin type 1 receptor blocker (ARB)-induced regression of sclerosis Macrophage polarization by angiotensin II-type 1 receptor aggravates renal injury-acceleration of atherosclerosis.Therapeutic approach to FSGS in children.Mineralocorticoid receptor blockade-a novel approach to fight hyperkalaemia in chronic kidney disease Kidney function can improve in patients with hypertensive CKD Mineralocorticoid Receptor Blocker Protects against Podocyte-Dependent Glomerulosclerosis Mechanisms of progression of chronic kidney disease Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan.Aldosterone-induced fibrosis in the kidney: questions and controversies New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone.PAI-1 and kidney fibrosis.An additive effect of eplerenone to ACE inhibitor on slowing the progression of diabetic nephropathy in the db/db mice.Effects of p53 on aldosterone-induced mesangial cell apoptosis in vivo and in vitro Aldosterone activates NF-kappaB in the collecting duct.The podocyte as a direct target for treatment of glomerular disease?Aldosterone and progression of kidney disease.Mineralocorticoid receptor activation in obesity hypertension.Which antihypertensive drugs are the most nephroprotective and why?Chronic kidney disease: a new look at pathogenetic mechanisms and treatment options.The selective mineralocorticoid receptor antagonist eplerenone is protective in mild anti-GBM glomeru-lonephritis Animal models of regression/progression of kidney disease Regulation of glomerular heparanase expression by aldosterone, angiotensin II and reactive oxygen species.Mineralocorticoid receptor blockade ameliorates peritoneal fibrosis in new rat peritonitis model.The role of renin angiotensin system inhibition in kidney repair.A Novel Aldosterone Antagonist Limits Renal Injury in 5/6 Nephrectomy.Eplerenone suppresses salt-induced vascular endothelial growth factor expression in the kidney.Combination therapy with irbesartan and efonidipine for attenuation of proteinuria in Dahl salt-sensitive rats.

P2860

Q24194979-7C18B3B3-D91E-464A-ABD4-602068262E46 Q24239909-42FB8841-800D-427E-904E-F8A849FD2236 Q24243615-512321E3-F8A7-4AD9-805D-18ED78F4F0A2 Q26768865-4931741D-FC17-461C-BC4A-7AC8F6E17875 Q26996385-86281600-F812-4C39-A411-4F5F6F475659 Q27010135-29863615-5D88-4B12-A9BA-6AD2C1A42C7A Q33414957-621F55F2-FDFC-43A0-AD58-3DC98B9E4FA5 Q33685938-2C87AC70-28F7-490C-8247-5E3A92E814B1 Q34288892-268558B6-10FE-479C-A73E-0E696E526372 Q34367664-CC90A67B-8E79-43B7-9CEE-1A8C7DA919CB Q34414019-F2F6AA92-D229-48CD-822A-028B8FED7807 Q34595011-7EA50217-DF66-4C68-ACFD-16542B01B72D Q34805601-0E2FC3B2-DACE-4FF2-AFC1-C0BB6362DC21 Q35581624-261D759B-F130-4F6C-9F5C-B4415F16FC9C Q35614311-BFD244B1-AFD4-473D-93C8-2C5EC31F43AB Q35626544-FDE81F9E-ACF1-4891-8E22-F099A82CFE6D Q35853283-FD520528-4B41-455B-9B13-5DB378BC0284 Q35868694-9BCFDD3B-E3C6-4210-BBAF-6AAE6324C2FD Q36120044-DFDDA284-EAE8-430A-946B-58FDF94C11BA Q36127484-A566654C-910F-404C-B039-A17385AA98B6 Q36662162-48BC9182-FD7B-4E15-8AE6-897F36A8833E Q36688855-96103B5C-1669-4C71-8319-F30353FC6D19 Q36788871-6102654B-BC23-4A7F-A1AD-42F190C9B13A Q36846526-B3DD898E-19F5-44DA-BF31-02F734CB32E1 Q36878533-BC50C1E3-184F-4ABB-A2A4-413282E4A117 Q36931242-6A2469EA-6DB1-4B8E-ADCD-7227CA903636 Q37042182-9554E3A0-F6B4-481A-BE9E-E185A14A9E48 Q37139449-88889603-9128-41C0-B705-73102F851733 Q37378291-1E152FF2-5435-487C-844B-F6EF16BAA81E Q37517178-0AEB648E-3D0D-456E-A93A-B2A9635C187F Q37803235-2D12698E-335E-41FE-B8BA-60C161FD08D5 Q38087529-96638581-A952-4773-9641-1932967DB892 Q38256462-D428A3F6-DC28-4C66-9F10-25DB2C6F7125 Q38365795-46DAD0E6-7ED3-4D17-9336-D1B84B7C60C2 Q39853500-68889374-95FD-455E-A604-917E4BD143D0 Q40000499-3758C602-0597-4D65-8F8F-CBB501B48F8D Q41206891-5C1DD7C3-6962-475A-B258-965FDC7F395F Q41367679-1BD5B6E8-A113-4AD3-B25E-97F0427FE85F Q42142772-4FEFF083-B460-4E86-BDB6-C5500B712A83 Q43045828-754A74C4-58F7-4CD8-9262-444952611D66

P2860

Regression of existing glomerulosclerosis by inhibition of aldosterone.

http://www.wikidata.org/entity/Q46726706

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Regression of existing glomerulosclerosis by inhibition of aldosterone.

@en

Regression of existing glomerulosclerosis by inhibition of aldosterone.

@nl

type

label

Regression of existing glomerulosclerosis by inhibition of aldosterone.

@en

Regression of existing glomerulosclerosis by inhibition of aldosterone.

@nl

prefLabel

Regression of existing glomerulosclerosis by inhibition of aldosterone.

@en

Regression of existing glomerulosclerosis by inhibition of aldosterone.

@nl

P1433

Q46726706-E095D49E-4FA5-4B74-B7D3-DEE42496AD27

P1476

Q46726706-0379CF01-C6E3-46E8-BF8C-9AC216BF6124

P2093

Q46726706-41FE52AB-2AE2-4AFC-A729-2712F9065A15

Q46726706-454FA90A-87EB-487C-B3D5-F0EA733848AF

Q46726706-91B0BA2C-47CF-4D1C-86CE-9E24A961D443

Q46726706-A6A92BA7-7801-4E75-8BA2-54DF7BD27E96

Q46726706-E069F9F8-3C34-4BCA-BFC6-97307E9EFF8E

P304

Q46726706-BF03321C-6269-480D-80CE-100CA17DC28B

P31

Q46726706-8AF70ACE-94DE-4829-90BB-BC146E4FD3C6

P356

Q46726706-3C4BD9E2-B280-4E5B-8741-B7CB8809C6F2

P433

Q46726706-3764BD9D-CA48-45E3-B597-CF97A909EE29

P478

Q46726706-5D669159-680F-4EF3-B062-8021DF5092BB

P577

Q46726706-B6237242-6484-4D6F-974A-2310A45E4F69

P5875

Q46726706-A97F4C7A-4302-4F9E-A07A-06798014F76F

P698

Q46726706-C6C73264-20CD-451A-8C2A-63B2C259760F

P356

P1433

Journal of the American Society of Nephrology

P1476

Regression of existing glomerulosclerosis by inhibition of aldosterone.

@en

P2093

Agnes B Fogo

http://www.w3.org/2001/XMLSchema#string

Jean Claude Aldigier

http://www.w3.org/2001/XMLSchema#string

Li-Jun Ma

http://www.w3.org/2001/XMLSchema#string

Nancy J Brown

http://www.w3.org/2001/XMLSchema#string

Talerngsak Kanjanbuch

http://www.w3.org/2001/XMLSchema#string

P304

3306-3314

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2004090804

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2005-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7572958

http://www.w3.org/2001/XMLSchema#string

P698

16192423

http://www.w3.org/2001/XMLSchema#string